mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |